Dr Feehan Limited in Afton, MN - Clinic/Center

Dr Feehan Limited is a primary clinic (Clinic/center) in Afton, Minnesota. The current practice location for Dr Feehan Limited is 3343 Saint Croix Trl S, Afton, Minnesota. For appointments, you can reach them via phone at (651) 436-9995. The mailing address for Dr Feehan Limited is 3343 Saint Croix Trl S, P.o. Box 68, Afton, Minnesota and phone number is (651) 436-9995.

Dr Feehan Limited is licensed to practice in * (Not Available) (license number ) and its NPI number is 1164737383. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (651) 436-9995.

Contact Information

	Dr Feehan Limited
	3343 Saint Croix Trl S Afton MN 55001-7301
	(651) 436-9995
	Not Available

Primary Care Clinic Profile

Full Name	Dr Feehan Limited
Speciality	Clinic/center
Location	3343 Saint Croix Trl S, Afton, Minnesota
Authorized Official Name and Position	Kathleen Ann Feehan-schmidt (PRESIDENT)
Authorized Official Contact	6514369995
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Feehan Limited 3343 Saint Croix Trl S P.o. Box 68 Afton MN 55001-7301 Ph: (651) 436-9995	Dr Feehan Limited 3343 Saint Croix Trl S Afton MN 55001-7301 Ph: (651) 436-9995

NPI Details:

NPI Number	1164737383
Provider Enumeration Date	08/12/2010
Last Update Date	08/12/2010

Medical Identifiers

Medical identifiers for Dr Feehan Limited such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1164737383	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
261Q00000X	Clinic/center	(* (Not Available))	Primary

News Archive

Centrix and CutisPharma enter promotional agreement for vaginal suppository compounding kits

Centrix Pharmaceutical, Inc., a privately-held specialty pharmaceutical company focused on Pediatrics and Women's Health, announces a promotional agreement with CutisPharma, Inc., a Woburn, Massachusetts based company.

Data from ESTEVE's S1RA E-52862 Phase I trial programme on pain

ESTEVE announces the recent publication of data from the Phase I clinical trial programme of a novel, highly potent and selective, once-daily, S1RA E-52862, developed by the ESTEVE R&D team, in the British Journal of Clinical Pharmacology.

First-in-human phase 0 study shows clinically-relevant activity of new drug in glioblastoma

Combating glioblastoma remains a major challenge due the complex nature of these tumors, the inability of drugs to penetrate the brain tissue, and lack of correlation between animal models and the human condition.

Planet opens new club in Tyler on May 29

Planet Fitness is proud to announce the grand opening of a new club in Tyler, at 2747 East 5th Street, at Loop 323. The club officially opened on May 29th and is offering grand opening memberships for just $1 down through June 20th.

Dr Feehan Limited - Primary Care in Afton, MN